Scott Eliasof Email

SVP Research . Frequency Therapeutics

Current Roles

Employees:
29
Revenue:
$24M
About
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the controlled activation of progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. Our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the U.S. alone.
Frequency Therapeutics Address
19 Presidential Way
Woburn, MA
United States
Frequency Therapeutics Email

Past Companies

Self-employedBiotech/Pharma Consultant
Frequency TherapeuticsSenior Vice President of Research
Cerulean Pharma Inc.Senior Vice President and Chief Scientific Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.